Metabolic compromise in women with PCOS: earlier than expected

SUMMARY Polycystic ovary syndrome (PCOS) is an endocrinopathy with unknown pathophysiology among women of reproductive age. Several studies have been conducted to determine the prevalence of metabolic syndrome (MetS) among PCOS patients. Recent studies have reported varied prevalence of metabolic sy...

Full description

Saved in:
Bibliographic Details
Published in:Revista da Associação Médica Brasileira (1992) 2020-09, Vol.66 (9), p.1225-1228
Main Authors: Lana, Maria Perez, Demayo, Sandra, Giannone, Lorena, Nolting, Manuel, D'isa, Estela, Servetti, Valeria, Rolo, Guadalupe, Gutierrez, Guillermo, Jarlip, Mariana
Format: Magazinearticle
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SUMMARY Polycystic ovary syndrome (PCOS) is an endocrinopathy with unknown pathophysiology among women of reproductive age. Several studies have been conducted to determine the prevalence of metabolic syndrome (MetS) among PCOS patients. Recent studies have reported varied prevalence of metabolic syndrome (MetS) in women with PCOS. The aim of this study is to determine if women with PCOS are at a higher risk of MetS or some degree of metabolic compromise. METHODS: This is an observational study. A total of 96 women diagnosed with PCOS (according to the Rotterdam consensus criteria) were included. Variables of diagnostic criteria for MetS according to the ATP III were analyzed at the first consultation. Data analysis was performed using Epi Info™ 7.2.2.16. RESULTS: We assessed the prevalence of obesity, blood pressure, glucose intolerance, and dyslipidemia in 96 women with PCOS and an average age of 28 (17-39) years. Forty percent of the women had BMI
ISSN:0104-4230
1806-9282
DOI:10.1590/1806-9282.66.9.1225